Showing 321 - 330 of 455
Persistent link: https://www.econbiz.de/10007632111
Based on a survey of the inventors of 9,017 European patented inventions, this paper provides new information about the characteristics of European inventors, the sources of their knowledge, the importance of formal and informal collaborations, the motivations to invent, and the actual use and...
Persistent link: https://www.econbiz.de/10005124480
DOMESTIC MARKETS AND INTERNATIONAL COMPETITIVENESS This paper develops a theoretical and empirical model to analyze the effects of the size and nature of domestic markets on the international competitiveness of national industries. We validate our theory using data on the more than 20,000 plants...
Persistent link: https://www.econbiz.de/10005134442
Persistent link: https://www.econbiz.de/10005135484
This paper measures differences in the innovation performance of different types of firms in the pharmaceutical industry. We compare the innovation performance of incumbent firms with entrants, controlling for differences in the scale and scope of research, both at the firm level and at the...
Persistent link: https://www.econbiz.de/10005061689
This paper estimates the "production function" for scientific research publications in the field of biotechnology. it utilises an exceptionally rich and comprehensive data set pertaining to the universe of research groups that applied to a 1989-1993 research programme in biotechnology and...
Persistent link: https://www.econbiz.de/10005066244
Persistent link: https://www.econbiz.de/10005072973
This paper offers some reflections on the institutions for the governance of knowledge as an economic asset, and its management in firms. It then relies on a research based on a survey of a large number of patents (PatVal-EU) to discuss specific features of the invention system in Italy. The...
Persistent link: https://www.econbiz.de/10005049618
The report examines the competitive position of the European pharmaceutical companies and industries, and compares them with the pharmaceutical companies and industries in other parts of the world, particularly the US. Over the last two decades, the industry has experienced some important...
Persistent link: https://www.econbiz.de/10005034968
This paper explored an unusually comprehensive dataset of more than 2,000 drug R&D projects all over the world during the 1990s. This enabled us to characterise several features of the innovation process in pharmaceuticals, particularly the different role and comparative R&D performance of the...
Persistent link: https://www.econbiz.de/10005034980